Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effects of Dexmedetomidine on Oxidative Stress, Inflammatory Response, Coagulation Function and Hemodynamics in Patients Undergoing Hysterectomy

View through CrossRef
<i>Objective</i> To investigate the effects of dexmedetomidine on oxidative stress, inflammatory response, coagulation function and hemodynamics in patients undergoing hysterectomy. <i>Methods</i> 92 patients who underwent hysterectomy in our hospital from January to September 2023 were selected as subjects. According to the difference in anesthesia, 46 patients were in the control group and 46 in the dexmedetomidine group. Patients in the control group received midazolam anesthesia, and patients in the dexmedetomidine group received dexmedetomidine anesthesia. The changes of oxidative stress, inflammatory response, coagulation function and hemodynamics were compared between T0 (before anesthesia), T1 (10 min after anesthesia), T2 (after extubation) and T3 (24 h after surgery). <i>Results</i> At T0, there was no significant difference in T-AOC, GSH-Px, MBP, MCP-1, AT III, FDP, MAP and SpO<sub>2</sub> between the two groups (<I>P</I>>0.05). At the time of T1, T2 and T3, the two groups of patients T-AOC, GSH-Px were all lower than T0 (<I>P</I><0.05), MBP and MCP-1 were all higher than T0 (<I>P</I><0.05). The levels of T-AOC and GSH-Px in the dexmedetomidine group were significantly higher than those in the control group (<I>P</I><0.05). The levels of MCP-1 was significantly lower than that of the control group (<I>P</I><0.05). At the T1 and T2, ATIII levels was lower than T0 (<I>P</I><0.05), and FDP levels was higher than T0 (<I>P</I><0.05). At the time of T3, the levels of ATIII and FDP in the dexmedetomidine group recovered to the normal level of T0. There was no significant change in MAP and SpO<sub>2</sub> at each time in the dexmedetomidine group (<I>P</I>>0.05). <i>Conclusion</i> Dexmedetomidine can more effectively alleviate the oxidative stress response in patients with hysterectomy, reduce the symptoms of inflammation in patients, improve the coagulation status of patients and have less influence on hemodynamics, and have high clinical value.
Title: Effects of Dexmedetomidine on Oxidative Stress, Inflammatory Response, Coagulation Function and Hemodynamics in Patients Undergoing Hysterectomy
Description:
<i>Objective</i> To investigate the effects of dexmedetomidine on oxidative stress, inflammatory response, coagulation function and hemodynamics in patients undergoing hysterectomy.
<i>Methods</i> 92 patients who underwent hysterectomy in our hospital from January to September 2023 were selected as subjects.
According to the difference in anesthesia, 46 patients were in the control group and 46 in the dexmedetomidine group.
Patients in the control group received midazolam anesthesia, and patients in the dexmedetomidine group received dexmedetomidine anesthesia.
The changes of oxidative stress, inflammatory response, coagulation function and hemodynamics were compared between T0 (before anesthesia), T1 (10 min after anesthesia), T2 (after extubation) and T3 (24 h after surgery).
<i>Results</i> At T0, there was no significant difference in T-AOC, GSH-Px, MBP, MCP-1, AT III, FDP, MAP and SpO<sub>2</sub> between the two groups (<I>P</I>>0.
05).
At the time of T1, T2 and T3, the two groups of patients T-AOC, GSH-Px were all lower than T0 (<I>P</I><0.
05), MBP and MCP-1 were all higher than T0 (<I>P</I><0.
05).
The levels of T-AOC and GSH-Px in the dexmedetomidine group were significantly higher than those in the control group (<I>P</I><0.
05).
The levels of MCP-1 was significantly lower than that of the control group (<I>P</I><0.
05).
At the T1 and T2, ATIII levels was lower than T0 (<I>P</I><0.
05), and FDP levels was higher than T0 (<I>P</I><0.
05).
At the time of T3, the levels of ATIII and FDP in the dexmedetomidine group recovered to the normal level of T0.
There was no significant change in MAP and SpO<sub>2</sub> at each time in the dexmedetomidine group (<I>P</I>>0.
05).
<i>Conclusion</i> Dexmedetomidine can more effectively alleviate the oxidative stress response in patients with hysterectomy, reduce the symptoms of inflammation in patients, improve the coagulation status of patients and have less influence on hemodynamics, and have high clinical value.

Related Results

Radical Hysterectomy Versus Simple Hysterectomy and Brachytherapy for Patients with Stage II Endometrial Cancer
Radical Hysterectomy Versus Simple Hysterectomy and Brachytherapy for Patients with Stage II Endometrial Cancer
Abstract BACKGROUND: To compare the survival outcome between radical hysterectomy and simple hysterectomy with implants radiation in patients with stage II endometrial canc...
Hysterectomy and mental health status, findings from Ardakan Cohort Study on Aging (ACSA)
Hysterectomy and mental health status, findings from Ardakan Cohort Study on Aging (ACSA)
Abstract Background Many middle-aged and older women have undergone hysterectomy in their lifetime. The mental health outcomes of hysterectomy are controversial. This stud...
Efficacy of Dexmedetomidine for Reduction of Emergency Delirium in Children Undergoing Tonsillectomy in CMH Muzaffarabad AJK
Efficacy of Dexmedetomidine for Reduction of Emergency Delirium in Children Undergoing Tonsillectomy in CMH Muzaffarabad AJK
Background: Emergency delirium (ED) is a common and distressing complication in children recovering from anesthesia, particularly after tonsillectomy. Dexmedetomidine, a selective ...
ABDOMINAL VERSUS VAGINAL HYSTERECTOMY;
ABDOMINAL VERSUS VAGINAL HYSTERECTOMY;
Objective: To evaluate abdominal versus vaginal hysterectomy in relation to operative and post operative complications.Design: Single centre cross sectional study. Place and durati...
Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
Dexmedetomidine, an α2-adrenergic receptor agonist, is used as an anti-anxiety medication. It exerts a cholinergic effect, thereby reducing the release of tumor necrosis factor alp...
Role of Dexmedetomidine on post-traumatic stress response
Role of Dexmedetomidine on post-traumatic stress response
Objective: to explore the role of dexmedetomidine on the incidence of postoperative post traumatic stress response (PTSD) in trauma patients in the emergency department. Methods: T...

Back to Top